AU5553398A - Compounds with improved inductive effect on cartilage and bones - Google Patents

Compounds with improved inductive effect on cartilage and bones

Info

Publication number
AU5553398A
AU5553398A AU55533/98A AU5553398A AU5553398A AU 5553398 A AU5553398 A AU 5553398A AU 55533/98 A AU55533/98 A AU 55533/98A AU 5553398 A AU5553398 A AU 5553398A AU 5553398 A AU5553398 A AU 5553398A
Authority
AU
Australia
Prior art keywords
cartilage
bones
compounds
inductive effect
improved inductive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55533/98A
Other languages
English (en)
Inventor
Helmut Heide
Joachim Pabst
Michael Paulista
Jens Pohl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GERONTOCARE GmbH
Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH
Original Assignee
GERONTOCARE GmbH
Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7812132&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5553398(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by GERONTOCARE GmbH, Biopharm Gesellschaft zur Biotechnologischen Entwicklung von Pharmaka mbH filed Critical GERONTOCARE GmbH
Publication of AU5553398A publication Critical patent/AU5553398A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
    • A61L27/42—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix
    • A61L27/425—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having an inorganic matrix of phosphorus containing material, e.g. apatite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1875—Bone morphogenic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/227—Other specific proteins or polypeptides not covered by A61L27/222, A61L27/225 or A61L27/24
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Toxicology (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Inorganic Chemistry (AREA)
  • Composite Materials (AREA)
  • Materials Engineering (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU55533/98A 1996-11-19 1997-11-19 Compounds with improved inductive effect on cartilage and bones Abandoned AU5553398A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19647853 1996-11-19
DE19647853A DE19647853A1 (de) 1996-11-19 1996-11-19 Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender Aktivität
PCT/EP1997/006463 WO1998021972A2 (de) 1996-11-19 1997-11-19 Verbindungen mit verbesserter knorpel- und/oder knocheninduzierender aktivität

Publications (1)

Publication Number Publication Date
AU5553398A true AU5553398A (en) 1998-06-10

Family

ID=7812132

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55533/98A Abandoned AU5553398A (en) 1996-11-19 1997-11-19 Compounds with improved inductive effect on cartilage and bones

Country Status (7)

Country Link
US (1) US7365051B2 (https=)
EP (1) EP0942758B1 (https=)
JP (1) JP3807749B2 (https=)
AU (1) AU5553398A (https=)
DE (2) DE19647853A1 (https=)
ES (1) ES2210592T3 (https=)
WO (1) WO1998021972A2 (https=)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4388602B2 (ja) † 1997-02-07 2009-12-24 ストライカー コーポレイション マトリクスを含まない骨形成デバイス、移植片、およびその使用方法
DE19944681A1 (de) * 1999-08-20 2001-03-01 Metz Stavenhagen Peter Knochenersatzstoff zur Implantation im menschlichen oder tierischen Körper
CH695043A5 (de) * 2000-03-10 2005-11-30 Technology Finance Corp Implantat, das einen Körper aus nichtresorbierbarem bioaktivem Material umfasst.
ES2247423T5 (es) * 2001-11-19 2015-12-30 Scil Technology Gmbh Método de producción de un dispositivo recubierto homogéneamente que tiene propiedades osteoinductoras y osteoconductoras
ATE322916T1 (de) 2002-09-10 2006-04-15 Scil Technology Gmbh Unter verringerter sauerstoffkonzentration mit einem osteoinduktiven protein beschichtetes metallimplantat
AU2003277593A1 (en) * 2002-11-07 2004-06-07 Ichiro Ono Therapeutic device for osteogenesis
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
EP1604693A1 (en) 2004-06-09 2005-12-14 Scil Technology GmbH In situ forming scaffold, its manufacturing and use
EP1604694A1 (en) * 2004-06-09 2005-12-14 Scil Technology GmbH Composite device having osteoinductive and osteoconductive properties
US7837740B2 (en) 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
US7815926B2 (en) 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
CN101330934B (zh) * 2005-12-14 2013-03-20 Scil技术有限公司 一种用于骨再生的可模压的生物材料及其制备方法和用途
DE102005060761B4 (de) * 2005-12-16 2007-10-25 Alexakis, Antonis, Dr. med. dent. Formteil zur Neubildung von Knochenmaterial
EP1880731A1 (en) 2006-07-18 2008-01-23 BIOPHARM GESELLSCHAFT ZUR BIOTECHNOLOGISCHEN ENTWICKLUNG VON PHARMAKA mbH Human growth and differentiation factor GDF-5
US7723291B2 (en) * 2006-07-27 2010-05-25 Warsaw Orthopedic, Inc. Release of BMP, bioactive agents and/or cells via a pump into a carrier matrix
EP3345607B1 (en) * 2006-12-29 2022-10-26 Ossifi-Mab LLC Methods of altering bone growth by administration of sost or wise antagonist or agonist
HRP20120698T1 (hr) * 2007-01-25 2013-09-30 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka Mbh Uporaba dgf-5 za poboljšanje ili održavanje izgleda kože
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
US20090061002A1 (en) * 2007-09-05 2009-03-05 Venbrocks Rudolf A Calcium phospate based delivery of growth and differentiation factors to compromised bone
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
KR100991203B1 (ko) * 2010-05-10 2010-11-01 심영복 골형성 단백질의 정제 방법
EP2537538A1 (en) 2011-06-22 2012-12-26 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH Bioresorbable Wound Dressing
EP2602264A1 (en) 2011-12-05 2013-06-12 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Von Pharmaka mbH GDF-5 mutant for inducing cartilage formation
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
NZ746109A (en) 2016-12-30 2022-12-23 Biogend Therapeutics Co Ltd Recombinant polypeptides and nucleic acid molecules, compositions, and methods of making and uses thereof
US11324806B2 (en) 2018-10-19 2022-05-10 Warsaw Orthopedic, Inc. Sustained delivery of a growth differentiation factor
IL293988A (en) 2019-12-18 2022-08-01 Merck Patent Gmbh Use of a gdf-5 mutant in the treatment of pain and cartilage destruction

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4596574A (en) * 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
US4681763A (en) * 1985-06-11 1987-07-21 University Of Medicine And Dentistry Of New Jersey Composition for stimulating bone growth
DE3810803A1 (de) * 1988-03-30 1989-10-12 Battelle Institut E V Verfahren zur herstellung eines synthetischen knochenmaterials mit koerpereigenen eigenschaften
WO1991005802A1 (en) 1989-10-17 1991-05-02 Creative Biomolecules, Inc. Osteogenic devices
IL110589A0 (en) * 1993-08-10 1994-11-11 Bioph Biotech Entw Pharm Gmbh Growth/differentiation factor of the TGF- beta family
US6302913B1 (en) 1994-05-24 2001-10-16 Implico B.V. Biomaterial and bone implant for bone repair and replacement
US5866155A (en) * 1996-11-20 1999-02-02 Allegheny Health, Education And Research Foundation Methods for using microsphere polymers in bone replacement matrices and composition produced thereby

Also Published As

Publication number Publication date
ES2210592T3 (es) 2004-07-01
DE59711220D1 (de) 2004-02-19
WO1998021972A3 (de) 1998-09-17
EP0942758A2 (de) 1999-09-22
JP3807749B2 (ja) 2006-08-09
US7365051B2 (en) 2008-04-29
US20050169965A1 (en) 2005-08-04
JP2001505097A (ja) 2001-04-17
DE19647853A1 (de) 1998-05-20
EP0942758B1 (de) 2004-01-14
WO1998021972A2 (de) 1998-05-28

Similar Documents

Publication Publication Date Title
AU5553398A (en) Compounds with improved inductive effect on cartilage and bones
AU3380397A (en) Bone screw
HUP9900648A3 (en) Bone screw
AU1952797A (en) Page latch
AU1957597A (en) Security document
AU5241298A (en) Contrast enhancing illuminator
AU5752398A (en) Novel ketobenzamides and their use
AU4261697A (en) Compounds and methods
AU1699797A (en) Tangle-resistant leash
AU3818897A (en) Combined screw and clearance drill
AU4717797A (en) Inductor
PL331523A1 (en) Azolotrizines and azolopyrimidines
AU1965497A (en) Cardiotrophin and uses therefor
AUPM866394A0 (en) Improved waste bin
AU5596494A (en) Processing shark cartilage
GB2315463B (en) Tags and components thereof
AU3868497A (en) Benzenesulfone compounds and salts thereof
AU1451495A (en) Continuous composter
GB9616563D0 (en) Compounds and methods
AU2708597A (en) An improvement in the treatment of wastes
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
AU1303797A (en) Targeted compounds with cartilage formation-inducing and/or bone formation-inducing activity
AU2572697A (en) Orthopaedic materials
AU2153197A (en) Cripowellins and synthetic derivatives thereof
EP0934345A4 (en) CONNECTIONS AND PROCEDURE